Fetuin B Is a Secreted Hepatocyte Factor Linking Steatosis to Impaired Glucose Metabolism

R.C. Meex, A.J. Hoy, A. Morris, R.D. Brown, J.C. Lo, M. Burke, R.J. Goode, B.A. Kingwell, M.J. Kraakman, M.A. Febbraio, J.W. Greve, S.S. Rensen, M.P. Molloy, G.I. Lancaster, C.R. Bruce, M.J. Watt*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

42 Downloads (Pure)


Liver steatosis is associated with the development of insulin resistance and the pathogenesis of type 2 diabetes. We tested the hypothesis that protein signals originating from steatotic hepatocytes communicate with other cells to modulate metabolic phenotypes. We show that the secreted factors from steatotic hepatocytes induce pro-inflammatory signaling and insulin resistance in cultured cells. Next, we identified 168 hepatokines, of which 32 were differentially secreted in steatotic versus non-steatotic hepatocytes. Targeted analysis showed that fetuin B was increased in humans with liver steatosis and patients with type 2 diabetes. Fetuin B impaired insulin action in myotubes and hepatocytes and caused glucose intolerance in mice. Silencing of fetuin B in obese mice improved glucose tolerance. We conclude that the protein secretory profile of hepatocytes is altered with steatosis and is linked to inflammation and insulin resistance. Therefore, preventing steatosis may limit the development of dysregulated glucose metabolism in settings of overnutrition.
Original languageEnglish
Pages (from-to)1078-1089
JournalCell Metabolism
Issue number6
Publication statusPublished - 1 Jan 2015

Cite this